Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (68)	6/4/2001 8:42:27 PM
From: ewolf	Read Replies (1) \| Respond to of 222

Here we are more than a couple of months later with a significant rise in the stock. The process of bringing novel drugs to approval seems incredibly difficult. Does the rise in price change your feelings? Seems as if idph and crxa are basically even and that given the results of testing, both drugs will receive approval. Most likely the problems this time were more with the fda's caution rather than the company's filings. The potential here remains the same, only the cost of the shares has changed. Even at the present value, you probably viewed the stock as a buying opportunity. Just curious about what effect the fluctuation has on your judgement.